Teva Pharmaceutical Industries Limited (TLV: TEVA)

TLV: TEVA Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	91,385	42,146	35,617	27,480	34,000	36,967
Market Cap Growth	74.07%	18.33%	29.61%	-19.18%	-8.03%	-41.11%
Enterprise Value	150,727	109,242	106,456	99,359	115,222	131,520
Last Close Price	80.80	38.15	32.99	26.95	30.55	34.21
PE Ratio	-	-	-	21.19	-	-
PS Ratio	1.22	0.74	0.68	0.56	0.63	0.63
PB Ratio	3.20	1.44	1.18	0.79	0.96	0.71
P/FCF Ratio	14.92	13.90	9.72	37.44	16.58	47.99
P/OCF Ratio	11.00	8.55	6.37	11.07	8.70	14.31
EV/Sales Ratio	2.46	1.91	2.03	2.01	2.15	2.25
EV/EBITDA Ratio	8.40	7.00	7.63	7.25	7.77	8.58
EV/EBIT Ratio	11.08	9.54	11.37	10.38	11.73	14.02
EV/FCF Ratio	29.64	36.03	29.05	135.36	56.18	170.75
Debt / Equity Ratio	3.02	2.49	2.52	2.10	2.40	1.82
Debt / EBITDA Ratio	3.92	4.53	5.26	5.19	5.57	5.95
Debt / FCF Ratio	14.09	24.08	20.80	99.97	41.59	123.14
Asset Turnover	0.40	0.36	0.33	0.32	0.31	0.29
Inventory Turnover	2.10	2.09	2.08	2.02	2.02	2.04
Quick Ratio	0.49	0.54	0.57	0.61	0.51	0.56
Current Ratio	0.89	1.02	1.05	1.14	0.99	0.98
Return on Equity (ROE)	-17.52%	-7.35%	-25.19%	4.09%	-31.38%	-6.49%
Return on Assets (ROA)	5.56%	4.54%	3.63%	3.91%	3.53%	2.87%
Return on Capital (ROIC)	8.72%	6.77%	5.11%	5.31%	4.77%	3.89%
Earnings Yield	-4.70%	-4.78%	-24.15%	4.72%	-37.73%	-9.33%
FCF Yield	6.70%	7.19%	10.29%	2.67%	6.03%	2.08%
Buyback Yield / Dilution	-0.87%	-0.81%	-0.27%	-1.10%	-0.37%	-6.86%
Total Shareholder Return	-0.87%	-0.81%	-0.27%	-1.10%	-0.37%	-6.86%

Source: S&P Capital IQ. Standard template. Financial Sources.